CILP1 and NTproBNP in pulmonary hypertension and right ventricular pressure overload: a translational experimental study

Back

ESC Premium Access

CILP1 and NTproBNP in pulmonary hypertension and right ventricular pressure overload: a translational experimental study

Session: Molecular modifiers of pulmonary vascular disease

Topic: Pathophysiology and Mechanisms

Speaker: Doctor A. Garcia-Alvarez (Barcelona, ES)

Event: ESC Congress 2024

Congress Presentation

About the speaker

Doctor Ana Garcia-Alvarez

Hospital Clinic, University of Barcelona, Barcelona (Spain)

2 presentations

0 follower

7 more presentations in this session

Recruitment of CCR5-positive T cells in pulmonary vascular lesions in idiopathic- and connective tissue disease associated- pulmonary arterial hypertension

Speaker: Doctor K. Ohta-Ogo (Suita, JP)

Comprehensive bioinformatic analysis identified m6A methylation as an important regulator in mediating immune response during idiopathic pulmonary arterial hypertension

Speaker: Doctor N. Liu (Changsha, CN)

Improved prognosis prediction of idiopathic pulmonary arterial hypertension using targeted plasma proteomics in disease management

Speaker: Doctor Y. Yang (Beijing, CN)

Ambrisentan reverses the prosenescent and anti-autophagic effect of high glucose on human pulmonary artery endothelial cells exposed to hypoxia

Speaker: Doctor F. Biondi (IT)

PEDF upregulated in Ngfr-positive cells suppresses proliferation of pulmonary artery smooth muscle cells

Speaker: Doctor C. Goten (Kanazawa, JP)

Access the full session

Molecular modifiers of pulmonary vascular disease

Speakers: Doctor A. Garcia-Alvarez, Doctor K. Ohta-Ogo, Doctor N. Liu, Doctor Y. Yang, Doctor F. Biondi...

Access

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources